409A Valuation Basics: What Founders Need to Know

What Is Driver-Based Revenue Forecasting?

A revenue forecast is a projection of the money your business will earn over a defined future period. There are two ways to build one:

Top-down forecasting starts with the total addressable market and works down to a market share assumption: “The UK B2B software market is worth £10 billion. If we capture 0.1%, we generate £10 million in revenue.” Useful for sizing the opportunity, useless for operational planning. Investors have heard thousands of 0.1% market share projections and are rightly sceptical.

Bottom-up, driver-based forecasting starts with the specific activities that generate revenue: “We have capacity to run 20 outbound sales conversations per week. Our conversion rate is 10%. Our average contract value is £12,000 per year. That gives us 2 new customers per week, or roughly 100 new customers per year, generating £1.2 million in new ARR.” Every assumption in that chain is testable, improvable, and explainable.

Driver-based forecasting is also the input layer for your 3-statement model — your revenue drivers feed the income statement, which integrates with the balance sheet and cash flow statement.

Why a Revenue Forecast Startup Needs a Different Approach

Established businesses forecast revenue by extrapolating historical data. Startups do not have historical data. The entire forecast must be built on forward-looking assumptions rather than trend lines. A driver-based model built on transparent assumptions is actually more useful to an early-stage investor than a statistical extrapolation, because it makes the business logic explicit and discussable.

The Core Framework: Identify Your Revenue Drivers

Note upfront: 409A is a section of the US tax code, so this is primarily a US topic. If you are incorporated elsewhere, the equivalent concepts exist under different names and different rules, and the last section covers that. Throughout, this is educational content and not tax or legal advice.

What is a 409A valuation and who needs one?

A 409A valuation is an independent appraisal of the fair market value of a private company's common stock, performed by a qualified third party, used to set the exercise price of stock options so that those options are not treated as deferred compensation under section 409A of the US Internal Revenue Code.

You need one if you are a US company granting stock options to employees. That is essentially the whole test. It is not triggered by your size, your funding or your revenue. The first time you want to grant an option, you need a defensible fair market value for your common stock, and from that point on you need to keep it current.

The rule exists because of an obvious abuse. Without it, a company could grant options with a strike price of $0.01 when the shares were plainly worth $5.00, handing the employee $4.99 per share of immediate, untaxed value and calling it an option rather than compensation. Section 409A closes that by saying: if you grant an option with a strike price below fair market value, we will treat it as deferred compensation and tax it punitively.

The critical detail is who bears that punishment. It is not the company. It is the employee. If your strike price is later found to be below fair market value, the employee is taxed on the spread as it vests, before they have sold anything or received any cash, plus a 20% additional federal penalty tax, plus interest. An employee who never exercised, never sold and may never see a penny from your company receives a tax bill because your board approved a strike price without a valuation to support it.

That asymmetry is why founders should treat the 409A as a duty of care rather than a compliance chore. The person harmed by cutting this corner is not you.

Why is my common stock worth so much less than my preferred?

Because they are different securities with different rights, and the difference is worth real money. Your Series A investor paid $2.00 for a share that gets paid first, has a liquidation preference, has anti-dilution protection, has information rights and probably has a board seat. Your employee gets a share that has none of those things and sits at the bottom of the queue.

Take a company that has just closed a $6m Series A at a $24m post-money, $2.00 per share, 1x non-participating preferred. The appraiser's job is to work out what a share of common is worth on the same day.

Start with the total equity value. The appraiser will triangulate this rather than simply accepting the post-money, but say they land on an enterprise value close to it. The post-money of $24m reflects what an investor paid for preferred stock. That $24m is not evenly spread across all shares, because the preferred shares carry a $6m preference that pays out before common sees anything.

Allocate the value. This is the step that produces the discount, and there are three common approaches.

The simplest is the current value method, which allocates today's equity value across the classes according to their rights as if the company were sold today. If the company sold for $24m today, the preferred takes its $6m preference or converts, whichever is better. Converting gives it 25% of $24m, which is $6m, exactly equal to the preference. So the preferred is indifferent, and the remaining $18m goes to the common. That method would say common is worth $18m across, say, 9,000,000 common shares, or $2.00 per share, which is clearly not the answer anyone reaches. The current value method is only used for very early or distressed companies precisely because it ignores the future.

The method that actually gets used for venture-backed companies is the option pricing model, usually a Black-Scholes based backsolve. It treats each class of stock as a call option on the company's future equity value. The insight is that common stock only has value in outcomes above the preference stack, so it behaves like an option struck at the preference amount. Below $6m of exit value in our example, common is worth nothing. Between $6m and the conversion threshold, common gets whatever is left over. Above it, common shares proportionally.

Because common only pays in the good outcomes, and because those outcomes are uncertain and years away, the model discounts it heavily. Then a further discount for lack of marketability is applied, typically 20 to 40% for an early stage company, because a share you cannot sell is worth less than one you can.

So the chain looks like this for our company:

Step	Value
Series A price per preferred share	$2.00
Value per common share after allocating for preference rights	$0.90
Less discount for lack of marketability, say 40%	-$0.36
409A fair market value per common share	$0.54

Check the arithmetic: $0.90 x (1 - 0.40) = $0.54 ✓. And the discount to the preferred price: ($2.00 - $0.54) / $2.00 = 73.0% ✓.

A 409A coming in around a quarter to a third of the last preferred price is unremarkable for a company that has just raised its Series A. It compresses as the company matures: by Series C or D the gap typically narrows considerably, because the preference stack is smaller relative to the company's value, the outcomes are less uncertain, and marketability discounts shrink as an exit becomes more visible.

The practical consequence is good for you. A low 409A means low strike prices, which means options that are cheap for employees to exercise and worth a lot if things go well. Founders sometimes react to a low 409A as though it were an insult to the company's prospects. It is the opposite: it is the mechanism that lets you give your team meaningful upside. You want it low, defensibly.

You cannot want it arbitrarily low, however, which is where safe harbour comes in.

What is safe harbour and what does it actually protect?

Safe harbour is a presumption that shifts the burden of proof. If you obtain a valuation using an approved method, the tax authority presumes it is reasonable, and if they want to challenge it they must prove it was grossly unreasonable. Without safe harbour, you must prove it was reasonable.

That reversal is the entire value of the exercise. Proving a subjective valuation was reasonable, years later, against a party with hindsight and a strong incentive, is a bad position. Making them prove it was grossly unreasonable is a very good one.

Three routes to safe harbour exist. The independent appraisal route is what essentially everyone uses: a qualified independent appraiser values the stock, and the valuation is good for twelve months or until a material event, whichever comes first. There is also an illiquid start-up presumption, available to companies under ten years old with no public market, where the valuation is done by someone with significant relevant knowledge and experience and is set out in writing, and a binding formula route that is rare and inflexible in practice.

Note what safe harbour does not do. It does not make your valuation correct. It does not protect you if you gave the appraiser bad information, or if you sat on a term sheet at four times the valuation and did not mention it, or if you used a valuation that was stale at the grant date. The presumption is rebuttable, and the way it gets rebutted is by showing the company knew something the appraiser did not.

So the operational rule is simple: tell your appraiser everything, including the things that make the number go up. A founder who hides a pending acquisition offer to keep the strike price low has not saved anyone money. They have created a liability that surfaces during the acquisition's diligence, at the worst moment, and it lands on their employees.

When do I need to refresh my 409A?

Every twelve months as a matter of course, and immediately on any material event, whichever comes first. The twelve month rule is the easy part. The material event rule is where companies get caught.

A material event is anything that would meaningfully change what a buyer would pay for your common stock. The clear cases:

Closing a priced round. This is the most common trigger and the most obvious. New money at a new price is direct evidence of value.

A secondary transaction in your common stock. If founders or employees sold common shares to a buyer at arm's length, that is a real market price for exactly the security being valued, and it is very hard to argue around. A founder secondary can push your 409A up sharply, which is why the sequencing of grants and secondaries matters.

A signed term sheet or LOI for an acquisition. Not a casual conversation, but a real, signed document changes the picture materially.

Missing or dramatically beating your plan. A company that has tripled revenue since the last valuation, or one that has lost its largest customer and cut its forecast, has changed materially even without a transaction. This is the trigger companies most often ignore, in both directions.

A significant change to the capital structure, a large debt facility, a major legal event, or a fundamental change in the business model.

The pattern to avoid is what happens when a company closes a Series B in March, does not refresh, and grants options in June using a January valuation. Those grants are on a stale number that predates a material event, safe harbour is gone, and every one of those employees is exposed. The fix is procedural and costs nothing: make "is our 409A current, and has anything material happened since it was set?" a standing item on every board agenda where option grants are approved. Grants should be approved in batches, at board meetings, against a current valuation, and minuted. Keep the valuation report and the board consents together in your data room from day one, because they will be requested in every subsequent round and at exit, and reconstructing them later is miserable.

How does the appraiser actually arrive at a number?

Three approaches, usually weighted rather than chosen exclusively, then an allocation step and a marketability discount.

The market approach looks at what comparable companies are worth. For a venture-backed company this means two things: the backsolve from your own most recent financing, which is usually the most heavily weighted input because it is an actual arm's length transaction in your own stock, and comparable public company multiples applied to your metrics. If your appraiser is using revenue multiples, they will care about your growth rate, your gross margin and your retention, which is one of several reasons the metrics discussed across our benchmarking posts are not merely for investors.

The income approach is a discounted cash flow. It takes your projections, discounts them at a rate reflecting the risk, and produces a present value. For a pre-revenue or early revenue company this method carries little weight, because a DCF built on a forecast where every material assumption is a guess is arithmetic dressed as evidence. It matters more as you mature and your forecasts have a track record. This is a reason to keep your 3-statement model credible: if you hand the appraiser a forecast showing $80m of revenue in year three with no basis, they will either discount it to irrelevance or, worse, take it seriously and hand you a high 409A.

The asset approach values the company at the net value of its assets. It is used for holding companies and for distressed or pre-product businesses where there is essentially nothing else to go on.

Then the allocation. Whichever total equity value they arrive at gets allocated across your share classes according to the actual rights in your charter, which is why the appraiser will want your full cap table, your charter, and every financing document. The liquidation preference stack drives most of the discount, and if you have participating preferred or multiples above 1x, your common will be worth proportionally less. Your cap table needs to be accurate for this to work, and an appraiser working from a cap table that omits outstanding SAFEs or an unallocated pool is producing a number that will not survive scrutiny.

Then the discount for lack of marketability, which is where a good deal of professional judgement lives. The inputs are your expected time to liquidity and the volatility of comparable companies. Longer to exit and more volatile means a bigger discount.

What you provide, and provide honestly: a current cap table, your charter and financing documents, your financial statements, your forecast, your board materials, any secondary transactions, any acquisition interest, and a candid narrative of the business. The quality of the output tracks the quality of the input, and every piece of it will be checked in a future diligence process.

What does this cost, and what happens if I get it wrong?

A 409A from a reputable provider is typically a few thousand pounds and takes one to three weeks, less if bundled with cap table software. Refreshes are usually cheaper. Against the cost of getting it wrong, this is not a line item worth economising on.

Consider what "wrong" looks like. An employee holds 40,000 vested options with a $0.20 strike. It later emerges that fair market value at grant was $1.00, because the grant was made after a round closed but priced off a stale valuation. The spread is $0.80 per share, or $32,000.

Check: 40,000 x ($1.00 - $0.20) = $32,000 ✓.

Under 409A, that $32,000 becomes taxable as it vests, in the year it vests, whether or not the employee has exercised. Add the 20% additional federal penalty tax: $32,000 x 0.20 = $6,400. Add ordinary income tax at, say, 35%: $11,200. Add interest and any state penalties. The employee owes roughly $17,600 on shares they do not own, cannot sell, and may never profit from.

Check: $6,400 + $11,200 = $17,600 ✓.

Multiply that across every employee granted in the affected window and you have a problem measured in hundreds of thousands, plus the remediation cost, plus the disclosure in your next round's diligence, plus the conversation with your team about why their equity has generated a tax bill instead of a windfall.

The other failure mode is subtler and more common: the company that does not refresh before a big hiring push and grants everyone a strike price that is defensible but unnecessarily high, or the company that runs a founder secondary in the same month as a batch of new-joiner grants and moves the strike price up fourfold for the people it is trying to recruit. Neither of these is illegal. Both are avoidable with a fortnight of planning.

Three habits. Get the first 409A before your first grant, not after your first employee asks why their paperwork has not arrived. Refresh on a schedule and on material events, and make it a board agenda item rather than something the CFO remembers. And sequence your grants deliberately around known events: if you are about to close a round, get the grants for the people you have already hired approved beforehand, because the price will be lower and there is nothing improper about doing something before an event rather than after it.

One connection worth making explicitly. Your 409A is downstream of your operating reality, so the quality of your financial model shows up in the appraisal, and the appraisal shows up in what your team's equity is worth. These are not separate workstreams. If you are running tight on cash and thinking about the trade-offs, the runway and burn calculator is the place to start, and the same forecast discipline feeds the appraiser.

What if I am not a US company?

Then section 409A does not apply to you, but the underlying problem does, and the local rules are usually stricter about timing rather than looser.

Every developed tax system has some version of the same question: if you give an employee an equity instrument worth more than they paid for it, when and how is that taxed? The answers differ enormously.

In the UK, the relevant regime for most startups is EMI, which requires an agreed market valuation with HMRC before granting, has qualifying conditions on company size and activity, and offers genuinely favourable tax treatment when it works. The valuation agreement process is different from a 409A in mechanics but similar in intent, and the consequence of getting outside the EMI conditions is a materially worse tax outcome for the employee. Unapproved options and growth shares are the common alternatives, each with their own treatment.

Across the EU, treatment varies by member state and the differences are large enough to affect where you incorporate and where you hire. Some jurisdictions tax at grant, some at exercise, some at sale, and the difference between those three is the difference between a workable equity scheme and one that actively harms your employees.

The founder-level takeaway is jurisdiction-independent. Get a defensible valuation before you grant. Document it. Refresh it when things change. Tell your adviser the truth. Understand that the consequences of getting it wrong land on your employees rather than on you, and that they will find out at the worst possible time.

If you are a US company with employees abroad, or a foreign company with US employees, you have both problems at once and you need specific advice on the interaction. That is genuinely complicated and not something to work out from a blog post.

This is educational content, not tax, legal or accounting advice. Section 409A and its equivalents are technical, jurisdiction-specific and consequential, and the penalties for error fall on individuals who had no part in the decision. Engage a qualified adviser and a qualified appraiser before you grant options, not after.

Frequently Asked Questions

Can I use my last round's valuation as the strike price? No, and doing so would badly overprice your options. Your last round's price is the price of preferred stock, which carries a liquidation preference, anti-dilution protection and control rights that common stock does not have. Common is worth meaningfully less, often 60 to 80% less shortly after an early priced round. Using the preferred price as the strike would mean your employees pay several times fair value for their options, destroying the incentive the options exist to create. The whole purpose of the 409A is to establish what the common is worth as a distinct security.

How long does a 409A valuation last? Twelve months, or until a material event occurs, whichever comes first. The twelve month clock is straightforward. The material event condition is where companies get into trouble, because it is a judgement call and it is easy to convince yourself nothing important has happened. Closing a round, a secondary sale of common stock, a signed acquisition LOI, or a dramatic change in performance against plan all reset the clock. If you find yourself arguing that a material event was not really material, get advice rather than winning the argument with yourself.

Who pays if the strike price turns out to be too low? The employee, which is the single most important thing to understand about this topic. Section 409A penalties fall on the option holder: they face immediate income tax on the spread as it vests, a 20% additional federal penalty tax, and interest, on paper gains from shares they may not own and cannot sell. The company faces withholding and reporting obligations and, in practice, an obligation to fix a problem it created. Many companies end up making affected employees whole, which is expensive and awkward. The person who bears the risk of your compliance shortcut is the person with the least ability to assess it.

Does a 409A valuation affect my fundraising valuation? No, and investors will not be confused by the difference even if it feels uncomfortable to show them. A 409A values common stock for tax purposes using a specific, conservative methodology with heavy discounts for illiquidity and preference. A fundraising valuation is what a specific investor will pay for preferred stock with preference, anti-dilution and control rights, based on their view of your future. A $0.54 409A alongside a $2.00 Series A price is entirely normal and every investor has seen hundreds of them. Do not attempt to inflate your 409A to look better in a pitch; the only effect is to make your employees' options more expensive.

Can I do the 409A myself to save money? Technically the illiquid start-up presumption allows a valuation by someone with significant relevant knowledge and experience rather than a formal independent appraiser, but in practice this is a poor trade. A self-prepared valuation invites scrutiny of both the number and the preparer's independence, and it will be examined in every future round's diligence and again at exit. Any acquirer's counsel will look at a founder-prepared 409A with interest. The cost of a proper appraisal is small relative to a single employee's remediation, let alone a deal issue found late. Spend the money.

Further Reading

• What Is a Startup Financial Model?
• The Rule of 40 Explained
• Churn Rate Calculation and Cohort Analysis
• Runway and Burn Calculator
• Financial Model Pro